While the initial results of clinical trials are promising, the long-term efficacy and sustainability of GLP-1 analogue treatments depend on the adoption of healthy lifestyle changes
For patients who have been paying for Ozempic or other glucagon-like peptide-1 medications, there may be another beneficial development: On December 23, the U.S
PlexusDx Precision Peptide Genetic Test identifies your personal risk profile across 14 metabolic pathways, helping you and your healthcare provider create a tailored maintenance plan before stopping medication
Solving dosing problems with individualized, patient-specific dosing Avoiding additives making medications that are dye-free, preservative-free and lactose-free Recreating discontinued meds making medications that may no longer be commercially available Customizing strengths compounding the exact prescribed strength a patient needs Adding flavoring helping make the medicine go down easier and improve compliance What we compound A wide range of compounds, tailored to each patient
However, there are a number of natural techniques that have been demonstrated to work
McGuire DK et al